BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 8612531)

  • 21. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys.
    LeRoith D; Yanowski J; Kaldjian EP; Jaffe ES; LeRoith T; Purdue K; Cooper BD; Pyle R; Adler W
    Endocrinology; 1996 Mar; 137(3):1071-9. PubMed ID: 8603576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
    Mauras N; Doi SQ; Shapiro JR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of GH and IGF-I in the regulation of IGF-I, IGF-I receptor and IGF binding protein gene expression in the rat spleen.
    Domené HM; Meidan R; Yakar S; Shen-Orr Z; Cassorla F; Roberts CT; LeRoith D
    Regul Pept; 1994 Aug; 52(3):215-26. PubMed ID: 7528435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
    Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver.
    Maiter D; Walker JL; Adam E; Moatsstaats B; Mulumba N; Ketelslegers JM; Underwood LE
    Endocrinology; 1992 Jun; 130(6):3257-64. PubMed ID: 1375898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of recombinant human insulin-like growth factor-1 and recombinant human growth hormone on anabolism and immunity in calorie-restricted alcoholic rats.
    Mendenhall CL; Roselle GA; Gartside P; Grossman CJ
    Alcohol Clin Exp Res; 1997 Feb; 21(1):1-10. PubMed ID: 9046366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury.
    Klein GL; Wolf SE; Langman CB; Rosen CJ; Mohan S; Keenan BS; Matin S; Steffen C; Nicolai M; Sailer DE; Herndon DN
    J Clin Endocrinol Metab; 1998 Jan; 83(1):21-4. PubMed ID: 9435411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
    Melián E; Velasco B; Barrios R; Sanchez-Franco F
    Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 14-day infusions of growth hormone and/or insulin-like growth factor I on the obesity of growing Zucker rats.
    Dubuis JM; Deal C; Tsagaroulis P; Clark RG; Van Vliet G
    Endocrinology; 1996 Jul; 137(7):2799-806. PubMed ID: 8770900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively.
    Labarta JI; Gargosky SE; Simpson DM; Lee PD; Argente J; Guevara-Aguirre J; Rosenfeld RG
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):657-66. PubMed ID: 9497872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.
    Sass DA; Jerome CP; Bowman AR; Bennett-Cain A; Ginn TA; LeRoith D; Epstein S
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1202-9. PubMed ID: 9100597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
    Lieberman SA; Bukar J; Chen SA; Celniker AC; Compton PG; Cook J; Albu J; Perlman AJ; Hoffman AR
    J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of amino acid solution and recombinant human growth hormone on growth hormone/insulin like growth factor-1 axis in rats with liver cirrhosis].
    Liang LJ; Luo SM; Hu WJ
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):697-701. PubMed ID: 16008955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.
    Cheetham TD; Holly JM; Baxter RC; Meadows K; Jones J; Taylor AM; Dunger DB
    J Endocrinol; 1998 Apr; 157(1):81-7. PubMed ID: 9614361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
    Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M
    J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.